Kayıkçıoğlu, Erkan, and Arif Hakan Onder. “The Pan-Immune-Inflammation-Value Predicts the Survival of Patients With Estrogen Receptor-Positive,Human Epidermal Growth Factor Receptor 2 (HER2)—Negative Metastatic Breast Cancer Breast Cancer Treated With CDK4/6 Inhibitors: Pan-Immune-Inflammation-Value in Metastatic Breast Cancer Breast Cancer Treated With CDK4/6 Inhibitors”. Chronicles of Precision Medical Researchers 3, no. 3 (October 15, 2022). Accessed May 18, 2024. https://www.chronpmr.com/index.php/cpmr/article/view/145-149.